Prostate Cancer: Curing the Whole Family
https://vimeo.com/732073503/b8d30041bb Learning your family’s history with cancer is important. The link between some types of prostate cancer and other cancers through genetics has been known for some time, although it...Read More
Genomic Landscape of Metastatic Prostate Cancer Unveiled in New Study
A comprehensive genetic analysis of metastatic prostate cancer has, for the first time, revealed a number of major ways in which abnormal alterations of the genome propel this aggressive form...Read More
NIH and Prostate Cancer Foundation launch large study on aggressive prostate cancer in African-American men
The largest coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men has begun. The $26.5 million study is called RESPOND, or Research...Read More
FDA Approves Enzalutamide (Xtandi) for Non-Metastatic Castration-Resistant Prostate Cancer
July 13, 2018 – Today the U.S. Food and Drug Administration (FDA) approved enzalutamide (Xtandi) for the treatment of non-metastatic castration-resistant prostate cancer (non-metastatic CRPC). Non-metastatic CRPC is a clinical...Read More
Deadly Form of Advanced Prostate Cancer is Common, Calls for Distinct Treatment
Original article issued by UCSF News. A new study of prostate cancer in 202 men, whose cancers had spread and were resistant to standard treatment, found that a surprisingly large...Read More
Tumors Grown in the Lab Provide Insights on Rare Prostate Cancer
Original article issued by Weill Cornell Medicine. Growing miniature tumors from patient’s cells in the laboratory may help scientists personalize treatments for those with a rare form of prostate cancer,...Read More